Crosstalk between the CX3CL1/CX3CR1 Axis and Inflammatory Signaling Pathways in Tissue Injury

被引:44
|
作者
Zhuang, Quan [1 ,2 ]
Ou, Jiarui [4 ]
Zhang, Sheng [1 ,2 ,3 ]
Ming, Yingzi [1 ,2 ]
机构
[1] Cent S Univ, Transplantat Ctr, Xiangya Hosp 3, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[2] Natl Hlth Minist Transplantat Med, Res Ctr, Changsha 410013, Hunan, Peoples R China
[3] Wuhan Univ, Transplant Ctr, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China
[4] Cent S Univ, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
CX3CL1; CX3CR1; inflammatory signaling pathway; tissue injury; chemokines; pathology; NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; FRACTALKINE CX(3)CL1; CX3CL1-CX3CR1; AXIS; ACUTE-PANCREATITIS; CX3CR1; EXPRESSION; SCIATIC-NERVE; P38; MAPK; MICROGLIA; RECEPTOR;
D O I
10.2174/1389203720666190305165722
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During inflammation, chemokines play a central role by mediating the activation of inflammatory cascade responses in tissue injury. Among more than 200 chemokines, CX3CL1 is a special chemotactic factor existing in both membrane-bound and soluble forms. Its only receptor. CX3CR1, is a member of the G protein-coupled receptor superfamily. The CX3CL1/CX3CR1 axis can affect many inflammatory processes by communicating with different inflammatory signaling pathways, such as JAK-STAT, Toll-like receptor, MAPK, AKT, NF-kappa B, Wnt/beta-catenin, as well as others. These inflammatory networks are involved in much pathology. Determining the crosstalk between the CX3CL1/CX3CR1 axis and these inflammatory signaling pathways could contribute to solving problems in tissue injury, and the CX3CL1/CX3CR1 axis may he a better therapeutic target than inflammatory-signaling pathways for preventing tissue injury due to the complexity of inflammatory signaling networks.
引用
收藏
页码:844 / 854
页数:11
相关论文
共 50 条
  • [1] Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
    Wojdasiewicz, Piotr
    Turczyn, Pawel
    Dobies-Krzesniak, Barbara
    Frasunska, Justyna
    Tarnacka, Beata
    [J]. MEDIATORS OF INFLAMMATION, 2019, 2019
  • [2] The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders
    Pawelec, Paulina
    Ziemka-Nalecz, Malgorzata
    Sypecka, Joanna
    Zalewska, Teresa
    [J]. CELLS, 2020, 9 (10) : 1 - 17
  • [3] Modulating neurotoxicity through CX3CL1/CX3CR1 signaling
    Limatola, Cristina
    Ransohoff, Richard M.
    [J]. FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [4] CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases
    Subbarayan, Meena S.
    Joly-Amado, Aurelie
    Bickford, Paula C.
    Nash, Kevin R.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2022, 231
  • [5] Regulation of microglia neurotoxicity by CX3CR1 and CX3CL1
    Cardona, AE
    Huang, DR
    Sasse, ME
    Kidd, G
    Lira, S
    Cook, D
    Jung, S
    Littman, D
    Ransohoff, R
    [J]. FASEB JOURNAL, 2005, 19 (04): : A940 - A940
  • [6] Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
    Bian, Chao
    Zhao, Zhi-Qi
    Zhang, Yu-Qiu
    Lu, Ning
    [J]. PLOS ONE, 2015, 10 (03):
  • [7] CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?
    Zhuang, Quan
    Cheng, Ke
    Ming, Yingzi
    [J]. CURRENT GENE THERAPY, 2017, 17 (06) : 442 - 452
  • [8] Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway
    Stavros Apostolakis
    Demetrios Spandidos
    [J]. Acta Pharmacologica Sinica, 2013, 34 : 1251 - 1256
  • [10] CX3CR1/CX3CL1 axis in breast cancer pathology and its therapeutic use
    Singh, Rajesh
    Singh, Santosh Kumar
    Mishra, Manoj K.
    Lillard, James W.
    [J]. JOURNAL OF IMMUNOLOGY, 2020, 204 (01):